Site: 001-065 — Nashville, Tennessee

Site: 001-065 is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site: 001-065 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced or Metastatic Solid Tumors.

Sponsors: Day One Biopharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site: 001-065?

Site: 001-065 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site: 001-065 conducted?

Site: 001-065 has 1 clinical trials on record, with 1 currently active. Their work covers Advanced or Metastatic Solid Tumors.

Is Site: 001-065 accredited by Crixeo Health?

Site: 001-065 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site: 001-065?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.